Myriad Genetics (MYGN) Interest & Investment Income (2009 - 2026)
Myriad Genetics (MYGN) posted quarterly Interest & Investment Income of $700000.0 for Q1 2026, up 133.33% YoY from $300000.0 in Q1 2025, and down 12.5% sequentially from $800000.0 in Q4 2025.
Myriad Genetics (MYGN) Interest & Investment Income (2009 - 2026) Analysis & Trends
Myriad Genetics has disclosed Interest & Investment Income across 18 years of filings, most recently posting $700000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 133.33% year-over-year to $700000.0; the TTM figure through Mar 2026 stood at $2.2 million (up 57.14% YoY), while the FY2025 annual figure was $1.8 million, up 5.88% from the prior year.
- Interest & Investment Income fell to $700000.0 in Q1 2026, from $800000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for MYGN reached as high as $1.1 million in Q3 2022 and fell as low as $100000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $500000.0 (2023), against an average of $547058.8.
- Annual changes were most pronounced in 2022 — Interest & Investment Income jumped 900.0% — and 2024, when it sank 57.14%.
- A 5-year view of Interest & Investment Income shows it stood at $1.0 million in 2022, then declined by 30.0% to $700000.0 in 2023, then slumped by 57.14% to $300000.0 in 2024, then jumped by 166.67% to $800000.0 in 2025, then fell by 12.5% to $700000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $700000.0, $800000.0, and $500000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 6.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 233.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 27.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 597,000.00 |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 13.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 10.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 11.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | 700,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 700,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 600,000.00 |
| Dec 31, 2023 | 700,000.00 |
| Sep 30, 2023 | 600,000.00 |
| Jun 30, 2023 | 500,000.00 |
| Mar 31, 2023 | 700,000.00 |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.10 Mn |
| Jun 30, 2022 | 400,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 200,000.00 |